ATC-0175
From Wikipedia, the free encyclopedia
 |
|
| Identifiers | |
|---|---|
|
|
| IUPHAR/BPS | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C23H25F2N5O |
| Molar mass | 425.473 |
| 3D model (Jmol) | |
|
|
|
|
| (verify) | |
ATC-0175 is a drug used in scientific research, which is a selective, non-peptide antagonist at the melanin concentrating hormone receptor MCH1. In animal studies it has been shown to produce both anxiolytic and antidepressant actions, but without sedative or ataxic side effects.[1][2][3]
References[edit]
- ^ Chaki S, Funakoshi T, Hirota-Okuno S, Nishiguchi M, Shimazaki T, Iijima M, Grottick AJ, Kanuma K, Omodera K, Sekiguchi Y, Okuyama S, Tran TA, Semple G, Thomsen W (May 2005). "Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists". The Journal of Pharmacology and Experimental Therapeutics. 313 (2): 831–9. doi:10.1124/jpet.104.081711. PMID 15677346.
- ^ Kanuma K, Omodera K, Nishiguchi M, Funakoshi T, Chaki S, Semple G, Tran TA, Kramer B, Hsu D, Casper M, Thomsen B, Sekiguchi Y (September 2005). "Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1". Bioorganic & Medicinal Chemistry Letters. 15 (17): 3853–6. doi:10.1016/j.bmcl.2005.05.121. PMID 16002290.
- ^ Chaki S, Yamaguchi J, Yamada H, Thomsen W, Tran TA, Semple G, Sekiguchi Y (2005). "ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety". CNS Drug Reviews. 11 (4): 341–52. doi:10.1111/j.1527-3458.2005.tb00052.x. PMID 16614734.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
